gptkbp:instanceOf
|
medical device
|
gptkbp:administeredBy
|
injection
|
gptkbp:alternativeTo
|
Adrenaclick
Auvi-Q
generic epinephrine auto-injectors
|
gptkbp:approvedBy
|
gptkb:FDA
|
gptkbp:availableOn
|
various dosages
|
gptkbp:category
|
emergency medicine
auto-injector
allergy treatment
|
gptkbp:contains
|
epinephrine
|
https://www.w3.org/2000/01/rdf-schema#label
|
EpiPen
|
gptkbp:legalStatus
|
patent expired
regulated medical device
|
gptkbp:manufacturer
|
gptkb:Mylan
gptkb:Viatris
gptkb:Meridian_Medical_Technologies
|
gptkbp:marketedAs
|
1987
|
gptkbp:prescriptionStatus
|
prescription only (in some countries)
over-the-counter (in some countries)
|
gptkbp:priceControversy
|
2016 price increase
|
gptkbp:routeOfAdministration
|
intramuscular
subcutaneous
|
gptkbp:sideEffect
|
nausea
anxiety
headache
tremor
increased heart rate
|
gptkbp:storage
|
room temperature
avoid freezing
avoid light
|
gptkbp:usedFor
|
anaphylaxis
|
gptkbp:validOn
|
typically 12-18 months
|
gptkbp:website
|
https://www.epipen.com/
|
gptkbp:bfsParent
|
gptkb:EPI
gptkb:EpiPen_price_controversy
gptkb:Mylan
gptkb:Auto-inject
|
gptkbp:bfsLayer
|
7
|